Literature DB >> 10687321

Development and validation of the cancer fatigue scale: a brief, three-dimensional, self-rating scale for assessment of fatigue in cancer patients.

T Okuyama1, T Akechi, A Kugaya, H Okamura, Y Shima, M Maruguchi, T Hosaka, Y Uchitomi.   

Abstract

We herein describe the development and validation of the Cancer Fatigue Scale (CFS) for assessment of fatigue in cancer patients. We designed this scale specifically to reflect the nature of fatigue experienced by cancer patients, by using factor analysis; the CFS is a 15-item scale composed of 3 subscales (physical, affective, and cognitive subscales). Three hundred seven cancer patients participated in the validation phase. Construct validity, confirmed by repeating factor analysis, was good. Convergent validity, confirmed by a correlation between CFS and a visual analogue scale for fatigue, was also shown to be good (r = 0.67, P < 0.001). The CFS had good stability (average test-retest reliability r = 0.69, P < 0.001) and good internal consistency (Cronbach's alpha coefficient for all 15 items = 0.88). The present study indicates that the CFS is a brief, valid, and feasible measure of fatigue for use with cancer patients.

Entities:  

Mesh:

Year:  2000        PMID: 10687321     DOI: 10.1016/s0885-3924(99)00138-4

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  71 in total

Review 1.  ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials.

Authors:  Andrea M Barsevick; Charles S Cleeland; Donald C Manning; Ann M O'Mara; Bryce B Reeve; Jane A Scott; Jeff A Sloan
Journal:  J Pain Symptom Manage       Date:  2010-06       Impact factor: 3.612

2.  Qualities of fatigue and associated chronic conditions among older adults.

Authors:  Susan E Hardy; Stephanie A Studenski
Journal:  J Pain Symptom Manage       Date:  2010-06       Impact factor: 3.612

3.  Characterizing Fatigue: The Effects of Ethnicity and Acculturation.

Authors:  Elizabeth D Cordero; Jose S Loredo; Kate E Murray; Joel E Dimsdale
Journal:  J Appl Biobehav Res       Date:  2012-03-27

4.  Correspondence between daily and weekly fatigue reports in breast cancer survivors.

Authors:  Rajni Banthia; Vanessa L Malcarne; Scott C Roesch; Celine M Ko; Helen L Greenbergs; James W Varni; Georgia R Sadler
Journal:  J Behav Med       Date:  2006-05-16

Review 5.  A systematic review of the association between immunogenomic markers and cancer-related fatigue.

Authors:  L N Saligan; H S Kim
Journal:  Brain Behav Immun       Date:  2012-05-14       Impact factor: 7.217

6.  A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy.

Authors:  Eudocia Q Lee; Alona Muzikansky; Jan Drappatz; Santosh Kesari; Eric T Wong; Camilo E Fadul; David A Reardon; Andrew D Norden; Lakshmi Nayak; Mikael L Rinne; Brian M Alexander; Nils D Arvold; Lisa Doherty; Jennifer Stefanik; Debra LaFrankie; Sandra F Ruland; Julee Pulverenti; Katrina H Smith; Sarah C Gaffey; Samantha Hammond; Patrick Y Wen
Journal:  Neuro Oncol       Date:  2016-02-21       Impact factor: 12.300

Review 7.  Fatigue among patients with brain tumors.

Authors:  Arash Asher; Jack B Fu; Charlotte Bailey; Jennifer K Hughes
Journal:  CNS Oncol       Date:  2016-03-17

8.  Factors predicting fatigue in breast cancer patients.

Authors:  Shahpar Haghighat; Mohammad Esmail Akbari; Kourosh Holakouei; Abbas Rahimi; Ali Montazeri
Journal:  Support Care Cancer       Date:  2003-05-03       Impact factor: 3.603

9.  Fatigue predicts mortality in older adults.

Authors:  Susan E Hardy; Stephanie A Studenski
Journal:  J Am Geriatr Soc       Date:  2008-09-22       Impact factor: 5.562

10.  Fatigue in Brazilian cancer patients, caregivers, and nursing students: a psychometric validation study of the Piper Fatigue Scale-Revised.

Authors:  Dálete D C F Mota; Cibele A M Pimenta; Barbara F Piper
Journal:  Support Care Cancer       Date:  2008-11-06       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.